The obesity risk gene FTO influences body mass in chronic schizophrenia but not initial antipsychotic drug-induced weight gain in first-episode patients
Open Access
- 1 July 2013
- journal article
- Published by Oxford University Press (OUP) in International Journal of Neuropsychopharmacology
- Vol. 16 (6) , 1421-1425
Abstract
Genetic factors contribute to the individual variability in weight gain caused by several antipsychotic drugs. The FTO gene is associated with obesity in the general population; we have investigated whether a common risk polymorphism (rs9939609) in this gene is associated with antipsychotic drug-induced weight gain and obesity. Two samples were studied: (1) 93 first-episode patients receiving antipsychotic drugs for the first time and having body weight monitored for up to 12 months; (2) 187 chronic patients with schizophrenia assessed for measures of obesity and metabolic dysfunction. No association of FTO genotype with weight gain was found in initially drug-naive patients. The chronically treated patients had a significant association of genotype with body mass index (BMI), reflected in associations with waist circumference, waist:hip ratio and the frequency of central obesity. These findings indicate that FTO genotype has a major effect on body weight determined by BMI in chronically treated patients with schizophrenia.Keywords
This publication has 11 references indexed in Scilit:
- Effect of FTO, SH2B1, LEP, and LEPR Polymorphisms on Weight Gain Associated With Antipsychotic TreatmentJournal of Clinical Psychopharmacology, 2010
- The genetics of obesity: FTO leads the wayTrends in Genetics, 2010
- Metabolic side effects of antipsychotic drug treatment – pharmacological mechanismsPharmacology & Therapeutics, 2010
- Influence of 5-HT2Creceptor and leptin gene polymorphisms, smoking and drug treatment on metabolic disturbances in patients with schizophreniaThe British Journal of Psychiatry, 2008
- A Common Variant in the FTO Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult ObesityScience, 2007
- Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medicationSchizophrenia Research, 2006
- Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosisPharmacogenetics and Genomics, 2005
- Insulin Resistance and Increased Leptin Concentrations in Noncompliant Schizophrenia Patients but Not in Antipsychotic-Naive First-Episode Schizophrenia PatientsThe Journal of Clinical Psychiatry, 2004
- Effects of antipsychotics on fat deposition and changes in leptin and insulin levelsThe British Journal of Psychiatry, 2004
- Impaired Fasting Glucose Tolerance in First-Episode, Drug-Naive Patients With SchizophreniaAmerican Journal of Psychiatry, 2003